寇双庆, 李广平, 丛洪良. Ⅱ型糖尿病与非糖尿病患者经皮冠状动脉介入治疗特征的对比分析[J]. 心脏杂志, 2010, 22(5): 712-715.
    引用本文: 寇双庆, 李广平, 丛洪良. Ⅱ型糖尿病与非糖尿病患者经皮冠状动脉介入治疗特征的对比分析[J]. 心脏杂志, 2010, 22(5): 712-715.
    Comparative study of percutaneous coronary intervention in patients with or without Type II diabetes mellitus[J]. Chinese Heart Journal, 2010, 22(5): 712-715.
    Citation: Comparative study of percutaneous coronary intervention in patients with or without Type II diabetes mellitus[J]. Chinese Heart Journal, 2010, 22(5): 712-715.

    Ⅱ型糖尿病与非糖尿病患者经皮冠状动脉介入治疗特征的对比分析

    Comparative study of percutaneous coronary intervention in patients with or without Type II diabetes mellitus

    • 摘要: 目的: 比较冠心病(CHD)并发与不并发糖尿病(DM)患者行经皮冠状动脉介入治疗(PCI)操作特点,分析CHD并发DM患者冠状动脉病变特点,探讨临床上DM对PCI可能的影响。方法: 对2006年1月~2006年12月在天津市胸科医院依顺序进行的全部1 441例行PCI术并植入金属支架的患者进行回顾性分析,按是否伴有DM分为两组:DM组和非DM组。收集患者PCI治疗各项参数,包括病变类型、病变参数、植入支架参数等。应用SPSS10.0软件进行统计学检验,计数资料以 表示,P<0.05为差异有统计学意义。结果: 在1 441例行PCI的患者中,DM患者共计223人,占15.5%。 DM组C型病变比例明显高于非DM组(38.3% vs.19.7%;P<0.05)。DM组PCI治疗中治疗病变个数、植入支架个数明显多于非DM组(1.42±0.62 vs. 1.28±0.51;1.63±0.84 vs. 1.47±0.69,P<0.05),而植入支架直径DM组明显小于非DM组[(3.00±0.42)mm vs. ( 3.06±0.43)mm,P<0.05]。其余PCI操作技术特点差异无统计学意义。结论: CHD并发DM行PCI术者病变较非DM者更重;CHD并发DM患者进行PCI治疗时需要处理更多病变、植入更多支架,且支架直径较小;CHD并发DM患者接受PCI治疗的比例与非并发DM的CHD患者相比更低。

       

      Abstract: AIM: To compare the features of percutaneous coronary intervention (PCI) between coronary heart disease (CHD) patients complicated with or without diabetes. METHODS: A cohort of 1 441 consecutive CHD patients treated with PCI from January to December 2006 in Tianjin Chest Hospital were analyzed retrospectively. The patients were divided into two groups: CHD with diabetes mellitus group and CHD without diabetes mellitus group. PCI-related data were collected and compared between groups. RESULTS: Two hundred and twenty-three patients (15.5%) were found complicated with diabetes. Type C lesion was more prevalent in patients with diabetes than those without diabetes (38.3% vs. 19.7%; P<0.05). The number of treated lesions and implantation of stents and drug-eluting stents in diabetic group were higher than in the nondiabetic group (1.42±0.62 vs. 1.28±0.51; 1.63±0.84 vs. 1.47±0.69, P<0.05). The average stent diameter was smaller in the diabetic group compared with that in the nondiabetic group [(3.00±0.42) mm vs.(3.06±0.43) mm, P<0.05]. CONCLUSION: Coronary artery lesions are more serious in CHD patients complicated with diabetes mellitus. Therefore, more lesions are treated and more stents are implanted in patients complicated with diabetes. PCI intervention rate is lower in CHD patients complicated with diabetes compared with that in CHD patients without diabetes.

       

    /

    返回文章
    返回